Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.513
-0.076 (-12.87%)
At close: May 17, 2024, 4:00 PM
0.512
-0.001 (-0.23%)
After-hours: May 17, 2024, 7:59 PM EDT
Renalytix Market Cap
Renalytix has a market cap or net worth of $39.55 million as of May 17, 2024. Its market cap has decreased by -54.65% in one year.
Market Cap
39.55M
Enterprise Value
44.26M
1-Year Change
-54.65%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since July 17, 2020, Renalytix's market cap has decreased from $475.30M to $39.55M, a decrease of -91.68%. That is a compound annual growth rate of -47.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 39.60M | -12.97% |
May 16, 2024 | 45.50M | 3.88% |
May 15, 2024 | 43.80M | 31.93% |
May 14, 2024 | 33.20M | 7.44% |
May 13, 2024 | 30.90M | 0.32% |
May 10, 2024 | 30.80M | -2.53% |
May 9, 2024 | 31.60M | -1.25% |
May 8, 2024 | 32.00M | -7.25% |
May 7, 2024 | 34.50M | - |
May 6, 2024 | 34.50M | -1.43% |
May 3, 2024 | 35.00M | -7.65% |
May 2, 2024 | 37.90M | -4.05% |
May 1, 2024 | 39.50M | 14.16% |
Apr 30, 2024 | 34.60M | 2.37% |
Apr 29, 2024 | 33.80M | 7.64% |
Apr 26, 2024 | 31.40M | 0.64% |
Apr 25, 2024 | 31.20M | -1.89% |
Apr 24, 2024 | 31.80M | -9.14% |
Apr 23, 2024 | 35.00M | -6.17% |
Apr 22, 2024 | 37.30M | -6.98% |
Apr 19, 2024 | 40.10M | 2.30% |
Apr 18, 2024 | 39.20M | -5.54% |
Apr 17, 2024 | 41.50M | 0.73% |
Apr 16, 2024 | 41.20M | -2.14% |
Apr 15, 2024 | 42.10M | -5.61% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cara Therapeutics | 41.04M |
VYNE Therapeutics | 40.82M |
Eyenovia | 40.40M |
Inspira Technologies Oxy B.H.N. | 40.12M |
Cyclo Therapeutics | 39.89M |
OncoCyte | 39.49M |
Unicycive Therapeutics | 39.49M |
Quince Therapeutics | 38.89M |